Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Li-Hui Gu"'
Autor:
Jia‐Qi Zhu, Han Wu, Xu Li, Min‐Yu Li, Zhen‐Li Li, Xin‐Fei Xu, Li‐Hui Gu, Dong‐Xu Yin, Feng Shen, Dong‐Sheng Huang, Tian Yang
Publikováno v:
Advanced Science, Vol 11, Iss 9, Pp n/a-n/a (2024)
Abstract Hepatocellular carcinoma (HCC) is acknowledged as an immunosuppressive neoplasm, whereby the inactive microenvironment facilitates immune tolerance and evasion of HCC. Post‐surgical resected liver cancer exhibits a proclivity for relapse,
Externí odkaz:
https://doaj.org/article/9069476f636a464499dd41f7cd6f3aaa
Autor:
Si-Yu Liu, Chao Li, Li-Yang Sun, Ming-Cheng Guan, Li-Hui Gu, Dong-Xu Yin, Lan-Qing Yao, Lei Liang, Ming-Da Wang, Hao Xing, Hong Zhu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Xiang-Min Tong, Tian Yang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) and AFP-L3 (
Externí odkaz:
https://doaj.org/article/590af4d18bcd43bca900c1d143a34ddb
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1760 (2022)
Primary liver cancer is the seventh-most-common cancer worldwide and the fourth-leading cause of cancer mortality. In the current era of precision medicine, the diagnosis and management of liver cancer are full of challenges and prospects. Mesoporous
Externí odkaz:
https://doaj.org/article/ae44ac50264d484cad58120d69e97371
Publikováno v:
In Journal of Fuel Chemistry and Technology November 2018 46(11):1352-1358
Autor:
Shun-Chao Yang, Lei Liang, Ming-Da Wang, Xian-Ming Wang, Li-Hui Gu, Kong-Ying Lin, Ya-Hao Zhou, Ting-Hao Chen, Wei-Min Gu, Jie Li, Hong Wang, Zhong Chen, Chao Li, Lan-Qing Yao, Yong-Kang Diao, Li-Yang Sun, Cheng-Wu Zhang, Yong-Yi Zeng, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang
Publikováno v:
HPB. 25:81-90
The Eastern Staging System, which was specially developed for patients undergoing surgical resection for hepatocellular carcinoma (HCC), has been proposed for more than ten years. To prospectively validate the predictive accuracy of the Eastern stagi
Autor:
Ming-Da, Wang, Shi-Chuan, Tang, Chao, Li, Li-Yang, Sun, Xiao, Xu, Ying-Jian, Liang, Fu-Bao, Liu, Wei-Min, Gu, Xian-Ming, Wang, Ya-Hao, Zhou, Wan Yee, Lau, Cheng-Wu, Zhang, Lan-Qing, Yao, Yong-Kang, Diao, Li-Hui, Gu, Feng, Shen, Yong-Yi, Zeng, Tian, Yang
Publikováno v:
Annals of Surgical Oncology. 30:346-358
Although hepatitis B virus (HBV) infection remains the main cause of hepatocellular carcinoma (HCC) worldwide, metabolic syndrome, with its increase in prevalence, has become an important and significant risk factor for HCC. This study was designed t
Autor:
Wan-Li Duan1,2, Xue-Jie Wang2,3, Ai Guo2, Li-Hui Gu2, Zhi-Mei Sheng4, Hao Luo2, Li-Xia Yang1, Wen-Hao Wang5, Bao-Gang Zhang2,3 zhangbg@wfmc.edu.cn
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 17, p5622-5635. 14p.
Autor:
Lan-Qing Yao, Chao Li, Yong-Kang Diao, Lei Liang, Hang-Dong Jia, Shi-Chuan Tang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Li-Hui Gu, Timothy M. Pawlik, Wan Yee Lau, Cheng-Wu Zhang, Feng Shen, Kui Wang, Tian Yang
Publikováno v:
Hepatobiliary Surgery and Nutrition.
Autor:
Si-Yu, Liu, Chao, Li, Li-Yang, Sun, Ming-Cheng, Guan, Li-Hui, Gu, Dong-Xu, Yin, Lan-Qing, Yao, Lei, Liang, Ming-Da, Wang, Hao, Xing, Hong, Zhu, Timothy M, Pawlik, Wan Yee, Lau, Feng, Shen, Xiang-Min, Tong, Tian, Yang
Publikováno v:
Frontiers in oncology. 12
The GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) and AFP-L3 (included i
Autor:
Ming-Da Wang, Li-Yang Sun, Guo-Jun Qian, Chao Li, Li-Hui Gu, Lan-Qing Yao, Yong-Kang Diao, Timothy M. Pawlik, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang
Publikováno v:
International journal of surgery (London, England). 105
Alpha-fetoprotein (AFP) and prothrombin induced by vitamin K absence-II (PIVKA-II) are two commonly used biomarkers for detection and prognostic prediction of hepatocellular carcinoma (HCC). This study sought to evaluate and compare the use of these